切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2019, Vol. 05 ›› Issue (03) : 157 -160. doi: 10.3877/cma.j.issn.2095-9605.2019.03.008

所属专题: 文献

综述

内镜下胃内球囊减肥术临床应用进展
于新颖1, 白日星2,(), 徐有青1, 闫文貌2   
  1. 1. 100050 北京,首都医科大学附属北京天坛医院消化内科
    2. 100050 北京,首都医科大学附属北京天坛医院普外科
  • 收稿日期:2019-06-16 出版日期:2019-08-30
  • 通信作者: 白日星

Clinical application progress of endoscopic gastric balloon surgery for weight loss

Xinying Yu1, Rixing Bai2(), Youqing Xu1   

  • Received:2019-06-16 Published:2019-08-30
  • Corresponding author: Rixing Bai
引用本文:

于新颖, 白日星, 徐有青, 闫文貌. 内镜下胃内球囊减肥术临床应用进展[J]. 中华肥胖与代谢病电子杂志, 2019, 05(03): 157-160.

Xinying Yu, Rixing Bai, Youqing Xu. Clinical application progress of endoscopic gastric balloon surgery for weight loss[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2019, 05(03): 157-160.

[1]
Collaborators GBDO, Afshin A, Forouzanfar MH, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years[J]. The New England journal of medicine, 2017, 377(1): 13-27.
[2]
Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study[J]. The Lancet Oncology, 2015, 16(1): 36-46.
[3]
Polednak AP. Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers[J]. Cancer detection and prevention, 2008, 32(3): 190-199.
[4]
Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults[J]. The New England journal of medicine, 2003, 348(17): 1625-1638.
[5]
National Task Force on the P, Treatment of O. Overweight, obesity, and health risk[J]. Archives of internal medicine, 2000, 160(7): 898-904.
[6]
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery[J]. Obesity, 2013, 21(Suppl 1): S1-27.
[7]
Obeid NR, Malick W, Concors SJ, et al. Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data[J]. Surgery for obesity and related diseases, 2016, 12(1): 11-20.
[8]
Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011[J]. Obesity surgery, 2013, 23(4): 427-436.
[9]
Ali MR, Moustarah F, Kim JJ, American Society for M, Bariatric Surgery Clinical Issues C. American Society for Metabolic and Bariatric Surgery position statement on intragastric balloon therapy endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons[J]. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2016, 12(3): 462-467.
[10]
Force ABET, Committee AT, Abu Dayyeh BK, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies[J]. Gastrointestinal endoscopy, 2015, 82(3): 425-438.
[11]
Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis[J]. Obesity surgery, 2008, 18(7): 841-846.
[12]
Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss[J]. Obesity surgery, 2008, 18(12): 1611-1617.
[13]
Moura D, Oliveira J, De Moura EG, et al. Effectiveness of intragastric balloon for obesity: A systematic review and meta-analysis based on randomized control trials[J]. Surgery for obesity and related diseases, 2016,12(2): 420-429.
[14]
Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity[J]. Lancet, 1982, 1 (8265): 198-199.
[15]
Ulicny KS, Jr., Goldberg SJ, Harper WJ, et al. Surgical complications of the Garren-Edwards Gastric Bubble[J]. Surgery, gynecology & obstetrics,1988, 166(6): 535-540.
[16]
Benjamin SB, Maher KA, Cattau EL, et al. Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity[J]. Gastroenterology, 1988, 95(3): 581-588.
[17]
Gleysteen JJ. A history of intragastric balloons[J]. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2016, 12(2): 430-435.
[18]
Espinet-Coll E, Nebreda-Duran J, Gomez-Valero JA, et al. Current endoscopic techniques in the treatment of obesity[J]. Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva, 2012,104(2): 72-87.
[19]
Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? [J] Obesity surgery, 2005, 15(6): 864-870.
[20]
Fuller NR, Pearson S, Lau NS, et al. An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study[J]. Obesity, 2013, 21(8): 1561-1570.
[21]
Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics(R) intragastric balloon (BIB(R)). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons[J]. Obesity surgery, 2011, 21(1): 5-9.
[22]
Angrisani L, Lorenzo M, Borrelli V, et al. Is bariatric surgery necessary after intragastric balloon treatment?[J] Obesity surgery, 2006, 16(9): 1135-1137.
[23]
Ohta M, Kitano S, Kai S, et al. Initial Japanese experience with intragastric balloon placement[J]. Obesity surgery, 2009, 19(6): 791-795.
[24]
Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients[J]. Obesity surgery, 2005, 15(8): 1161-1164.
[25]
Lopasso FP, Sakai P, Gazi BM, et al. A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity[J]. Journal of clinical gastroenterology, 2008, 42(1): 48-53.
[26]
Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity[J]. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2015, 11(4): 874-881.
[27]
Brooks J, Srivastava ED, Mathus-Vliegen EM. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K.[J] Obesity surgery, 2014, 24(5): 813-819.
[28]
Genco A, Dellepiane D, Baglio G, et al. Adjustable intragastric balloon vs non-adjustable intragastric balloon: case-control study on complications, tolerance, and efficacy[J]. Obesity surgery, 2013, 23(7): 953-958.
[29]
Genco A, Ernesti I, Ienca R, et al. Safety and Efficacy of a New Swallowable Intragastric Balloon Not Needing Endoscopy: Early Italian Experience[J]. Obesity surgery, 2018, 28(2): 405-409.
[30]
Neto MG, Silva LB, Grecco E, et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases[J]. Surgery for obesity and related diseases, 2018, 14(2): 151-159.
[31]
Ozturk A, Akinci OF, Kurt M. Small intestinal obstruction due to self-deflated free intragastric balloon[J]. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2010,6(5): 569-571.
[1] 何金梅, 尹立雪, 谭静, 张文军, 王锐, 任梅, 廖明娇. 超声心肌做功技术对2型糖尿病患者潜在左心室心肌收缩功能损伤的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1029-1035.
[2] 袁成雪, 张宗霞, 许婷, 斯郎拉姆. 三种内镜手术治疗结肠息肉的效果及安全性观察[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 78-81.
[3] 纪凯伦, 郝少龙, 孙海涛, 韩威. 减重术后胆囊结石形成机制的新进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 100-103.
[4] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[5] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[6] 侯文运, 刘恒昌, 窦利州, 陈海鹏, 郑朝旭, 王贵齐, 王锡山. 腹部无辅助切口内镜引导下取标本的腹腔镜辅助右半结肠癌根治术(保留回盲部)(附视频)[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 436-440.
[7] 侯超, 潘美辰, 吴文明, 黄兴广, 李翔, 程凌雪, 朱玉轩, 李文波. 早期食管癌及上皮内瘤变内镜黏膜下剥离术后食管狭窄的危险因素[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 383-387.
[8] 孙欣欣, 刘军, 陈超伍, 孙超. 超声内镜引导细针穿刺抽吸术在胰腺占位性病变中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 418-421.
[9] 高显奎, 赵太云, 陆兴俊, 张洪领, 房修罗, 闫碧春, 王胤, 王永翠, 刘苗苗, 冉若男. 内镜电凝止血与组织胶注射治疗上消化道溃疡伴出血的疗效观察[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 452-455.
[10] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[11] 丁亚梅, 田野, 钱进, 陈梅, 季鸿颖. 良性胃溃疡出血患者内镜治疗术后再出血的危险因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 322-325.
[12] 邱春华, 张志宏. 1108例小肠疾病的临床诊断及检查策略分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 948-954.
[13] 王亚丹, 吴静, 黄博洋, 王苗苗, 郭春梅, 宿慧, 王沧海, 王静, 丁鹏鹏, 刘红. 白光内镜下结直肠肿瘤性质预测模型的构建与验证[J]. 中华临床医师杂志(电子版), 2023, 17(06): 655-661.
[14] 孟科, 李燕, 闫婧爽, 闫斌. 胶囊内镜胃通过时间的影响因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 671-675.
[15] 陈柯豫, 黄艳齐, 张玲利. 同时性多发早期食管癌及高级别上皮内瘤变的危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(05): 524-528.
阅读次数
全文


摘要